oxymatrine has been researched along with arsenic trioxide in 2 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (arsenic trioxide) | Trials (arsenic trioxide) | Recent Studies (post-2010) (arsenic trioxide) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 3,119 | 160 | 1,507 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Z; Fu, J; Gong, Y; Jin, L; Li, B; Sun, M; Yang, B; Zhang, K; Zhang, Y; Zhao, X | 1 |
| Fan, L; Feng, H; Jia, B; Lan, F; Li, L; Liu, Q; Wang, T; Wang, Y; Xiao, W; Xing, G; Ye, W; Yue, X; Zhao, L; Zhou, C | 1 |
2 other study(ies) available for oxymatrine and arsenic trioxide
| Article | Year |
|---|---|
Arsenic trioxide-induced hERG K(+) channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression.
Topics: Action Potentials; Alkaloids; Animals; Arsenic Trioxide; Arsenicals; Cardiovascular Agents; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; In Vitro Techniques; Matrines; Myocytes, Cardiac; Oxides; Patch-Clamp Techniques; Promoter Regions, Genetic; Quinolizines; Sp1 Transcription Factor; Up-Regulation | 2013 |
Protective effects of oxymatrine against arsenic trioxide-induced liver injury.
Topics: Alkaloids; Animals; Antioxidants; Arsenic Trioxide; Arsenicals; Blotting, Western; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Heme Oxygenase-1; Male; NF-E2-Related Factor 2; Oxidative Stress; Oxides; Quinolizines; Rats; Rats, Wistar; Signal Transduction | 2017 |